Skip to main content

NCBiotech News

  • Life science jobs in North Carolina have increased 7 percent since 2007, to more than 66,000 by the end of 2012. And despite the overall economic struggle to claw back from the Great Recession, life science salaries in the state rose nearly 13 percent, to $82,000, says a new report from Battelle,
  • Daniel Ren of Cary was among this year’s top 15 North American high school students in the 2014 International BioGENEius Challenge at the BIO International Convention in San Diego.
  • Morrisville-based Gentris, which provides storage and testing services to research laboratories, has received a $4.75 million buy-out offer from New Jersey-based Cancer Genetics, Inc. (CGI).
  • Just two days after his company’s promising cancer-fighting technology is featured on WRAL, Raleigh’s CBS affiliate, Heat Biologics CEO Jeff Wolf is participating in a panel discussion in the North Carolina Pavilion at the BIO International Convention in San Diego.
  • Weekly Grant Funding Opportunities
  • If dengue, chikungunya, West Nile and about 200 other mosquito-carried viruses have you concerned, you're in luck. North Carolina is the world vaccine leader. This top-tier bioscience state goes viral when vaccines are the topic.
  • The United Nations projects that by 2050, we’ll have nine billion people in the world. Those additional 1.8 billion people will need to eat. Where will all that food come from? It’s a question that North Carolina companies are researching in earnest. 
  • A $1.8 million federal grant has been awarded to the City of Clinton to help pay for water and sewer hookups to a planned $200 million investment: a 20-million-gallon-a-year cellulosic biofuel refinery in the Sampson County community.
  • North Carolina reigns, after more than three decades of growth and change in the industry, as the CRO epicenter of the world.
  • Seven years after construction began on the $1 billion Novartis Holly Springs cell culture vaccine manufacturing facility, federal regulators have approved the factory’s output of the revolutionary Flucelvax flu vaccine for sale in the United States.
  • Weekly Grant Funding Opportunities
  • Heat Biologics has come a long way in a short time. But the most recent part of that journey was just a few miles down the road, to the biopharmaceutical company’s new Durham headquarters and lab facility on Capitola Drive. That move will be celebrated in a July open house.
  • If you're launching an NC life science company, Friday, June 20 is the deadline for applications to pitch your company story to investors and colleagues at the 16th annual Southeast BIO Investor & Partnering Forum, to be held November 11-13 in Atlanta.
  • Weekly Grant Funding Opportunities
  • Weekly Grant Funding Opportunities
  • ECU scientists are excited they'll soon take delivery of an Ion Proton DNA sequencer to benefit collaborators from across the university, purchased with a $149,000 NCBiotech grant.
  • BioCryst moved its company headquarters to Durham from Alabama four years ago, and now the publicly traded clinical-stage pharmaceutical company is reporting positive results from an important clinical trial.
  • Weekly Grant Funding Opportunities
  • Nine ag biotech business leaders pitched their companies’ assets to more than 150 participants in the Ag Biotech Entrepreneurial Showcase 2014 Tuesday at NCBiotech. The event also included panel discussions and two keynote speeches by CEOs of two high-tech food companies.      
  • Weekly Grant Funding Opportunities


Subscribe to News & Events